Skip to main content
. 2023 Sep 22;8(1):141–146. doi: 10.1016/j.jseint.2023.08.019

Table II.

Thirty-day postoperative outcomes in patients with and without metabolic syndrome.

Postoperative complication No metabolic syndrome
Metabolic syndrome
P value
Number Percent Number Percent
Superficial SSI 60 0.25% 9 0.31% .564
Deep SSI 14 0.06% 3 0.10% .377
Organ space SSI 55 0.23% 3 0.10% .174
Wound dehiscence 16 0.07% 1 0.03% .516
DVT/Thrombophlebitis 74 0.31% 9 0.31% .991
Pulmonary embolism 65 0.27% 9 0.31% .723
Stroke/CVA 19 0.08% 3 0.10% .679
Pneumonia 101 0.43% 24 0.83% .003
Renal insufficiency 15 0.06% 8 0.28% <.001
Acute renal failure 6 0.03% 4 0.14% .009
Myocardial infarction 55 0.23% 17 0.59% <.001
Cardiac arrest 12 0.05% 2 0.07% .684
Sepsis 30 0.13% 9 0.31% .018
Septic shock 12 0.05% 1 0.03% .714
Bleeding transfusions 404 1.70% 66 2.28% .027
Failure to wean 26 0.11% 0 0.00% .998
Reintubation 39 0.16% 9 0.31% .085
Reoperation 313 1.32% 55 1.90% .012
Readmission 662 2.79% 113 3.90% <.001
Mortality 36 0.15% 6 0.21% .480
Nonhome discharge 1892 7.98% 377 13.02% <.001
Prolonged hospital stay (>3 days) 1386 5.84% 295 10.19% <.001

SSI, surgical site infection; DVT, deep vein thrombosis; CVA, cerebrovascular accident.

Bold P value indicates statistical significance with P value set to <.05.